Sfoglia per Autore
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment
2022-01-01 Maurelli, M; Bellinato, F; Gisondi, P; Girolomoni, G
Is risankizumab as needed administration a good option for patients with plaque psoriasis?
2022-01-01 Gisondi, P; Maurelli, M; Bellinato, F; Girolomoni, G
A case of genital primary syphilis with superimposed impetigo
2022-01-01 Moar, Agata; Maurelli, Martina; Geat, Davide; Girolomoni, Giampiero
Tailored biological treatment for patients with moderate-to-severe psoriasis
2023-01-01 Maurelli, Martina; Gisondi, Paolo; Girolomoni, Giampiero
Overview of Atopic Dermatitis in Different Ethnic Groups
2023-01-01 Chiricozzi, Andrea; Maurelli, Martina; Calabrese, Laura; Peris, Ketty; Girolomoni, Giampiero
The Combination of Dupilumab with Other Monoclonal Antibodies
2023-01-01 Gisondi, P.; Maurelli, M.; Costanzo, A.; Esposito, M.; Girolomoni, G.
Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience
2023-01-01 Maurelli, Martina; Girolomoni, Giampiero; Gisondi, Paolo
Eosinophilic annular erythema successfully treated with cyclosporine
2023-01-01 Maurelli, Martina; Colato, Chiara; Gisondi, Paolo; Girolomoni, Giampiero
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study
2023-01-01 Chiricozzi, A; Ferrucci, Sm; Di Nardo, L; Gori, N; Balato, A; Ortoncelli, M; Maurelli, M; Galluzzo, M; Munera Campos, M; Seremet, T; Caldarola, G; De Simone, C; Ippoliti, E; Torres, T; Gkalpakiotis, S; Conrad, C; Carrascosa, Jm; Bianchi, Luca; Argenziano, G; Ribero, S; Girolomoni, G; Marzano, Av; Peris, K
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study
2023-01-01 Chiricozzi, Andrea; DAL BELLO, Giacomo; Gori, Niccolò; Di Nardo, Lucia; Schena, Donatella; Caldarola, Giacomo; Maurelli, Martina; De Simone, Clara; Girolomoni, Giampiero; Peris, Ketty
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis
2023-01-01 Maurelli, Martina; Gisondi, Paolo; Bellinato, Francesco; Mantovani, Alessandro; Targher, Giovanni; Girolomoni, Giampiero
Price variability of TNF-α inhibitor biosimilars among European countries
2023-01-01 Geat, Davide; Gisondi, Paolo; Maurelli, Martina; Puig, Luis; Paul, Carle; Thaçi, Diamant; Iversen, Lars; Bellinato, Francesco; Girolomoni, Giampiero
Atopic Dermatitis in the Elderly Population
2023-01-01 Maurelli, Martina; Chiricozzi, Andrea; Peris, Ketty; Gisondi, Paolo; Girolomoni, Giampiero
Advanced Glycation End Products and Psoriasis
2023-01-01 Maurelli, Martina; Gisondi, Paolo; Girolomoni, Giampiero
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS)
2024-01-01 Gargiulo, Luigi; Ibba, Luciano; Malagoli, Piergiorgio; Amoruso, Fabrizio; Argenziano, Giuseppe; Balato, Anna; Bardazzi, Federico; Burlando, Martina; Giovanni Carrera, Carlo; Damiani, Giovanni; Dapavo, Paolo; Dini, Valentina; Franchi, Chiara; Maria Gaiani, Francesca; Girolomoni, Giampiero; Guarneri, Claudio; Lasagni, Claudia; Loconsole, Francesco; Valerio Marzano, Angelo; Maurelli, Martina; Megna, Matteo; Orsini, Diego; Sampogna, Francesca; Travaglini, Massimo; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS)
2024-01-01 Gargiulo, L; Ibba, L; Malagoli, Piergiorgio; Amoruso, F; Argenziano, G; Balato, A; Bardazzi, F; Burlando, M; Carrera, C G; Damiani, G; Dapavo, P; Dini, V; Fabbrocini, G; Franchi, C; Gaiani, F M; Girolomoni, G; Guarneri, C; Lasagni, C; Loconsole, F; Marzano, A V; Maurelli, M; Megna, M; Orsini, D; Sampogna, F; Travaglini, M; Valenti, M; Costanz, o. A.; Narcisi, A
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment | 1-gen-2022 | Maurelli, M; Bellinato, F; Gisondi, P; Girolomoni, G | |
Is risankizumab as needed administration a good option for patients with plaque psoriasis? | 1-gen-2022 | Gisondi, P; Maurelli, M; Bellinato, F; Girolomoni, G | |
A case of genital primary syphilis with superimposed impetigo | 1-gen-2022 | Moar, Agata; Maurelli, Martina; Geat, Davide; Girolomoni, Giampiero | |
Tailored biological treatment for patients with moderate-to-severe psoriasis | 1-gen-2023 | Maurelli, Martina; Gisondi, Paolo; Girolomoni, Giampiero | |
Overview of Atopic Dermatitis in Different Ethnic Groups | 1-gen-2023 | Chiricozzi, Andrea; Maurelli, Martina; Calabrese, Laura; Peris, Ketty; Girolomoni, Giampiero | |
The Combination of Dupilumab with Other Monoclonal Antibodies | 1-gen-2023 | Gisondi, P.; Maurelli, M.; Costanzo, A.; Esposito, M.; Girolomoni, G. | |
Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience | 1-gen-2023 | Maurelli, Martina; Girolomoni, Giampiero; Gisondi, Paolo | |
Eosinophilic annular erythema successfully treated with cyclosporine | 1-gen-2023 | Maurelli, Martina; Colato, Chiara; Gisondi, Paolo; Girolomoni, Giampiero | |
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study | 1-gen-2023 | Chiricozzi, A; Ferrucci, Sm; Di Nardo, L; Gori, N; Balato, A; Ortoncelli, M; Maurelli, M; Galluzzo, M; Munera Campos, M; Seremet, T; Caldarola, G; De Simone, C; Ippoliti, E; Torres, T; Gkalpakiotis, S; Conrad, C; Carrascosa, Jm; Bianchi, Luca; Argenziano, G; Ribero, S; Girolomoni, G; Marzano, Av; Peris, K | |
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study | 1-gen-2023 | Chiricozzi, Andrea; DAL BELLO, Giacomo; Gori, Niccolò; Di Nardo, Lucia; Schena, Donatella; Caldarola, Giacomo; Maurelli, Martina; De Simone, Clara; Girolomoni, Giampiero; Peris, Ketty | |
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis | 1-gen-2023 | Maurelli, Martina; Gisondi, Paolo; Bellinato, Francesco; Mantovani, Alessandro; Targher, Giovanni; Girolomoni, Giampiero | |
Price variability of TNF-α inhibitor biosimilars among European countries | 1-gen-2023 | Geat, Davide; Gisondi, Paolo; Maurelli, Martina; Puig, Luis; Paul, Carle; Thaçi, Diamant; Iversen, Lars; Bellinato, Francesco; Girolomoni, Giampiero | |
Atopic Dermatitis in the Elderly Population | 1-gen-2023 | Maurelli, Martina; Chiricozzi, Andrea; Peris, Ketty; Gisondi, Paolo; Girolomoni, Giampiero | |
Advanced Glycation End Products and Psoriasis | 1-gen-2023 | Maurelli, Martina; Gisondi, Paolo; Girolomoni, Giampiero | |
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS) | 1-gen-2024 | Gargiulo, Luigi; Ibba, Luciano; Malagoli, Piergiorgio; Amoruso, Fabrizio; Argenziano, Giuseppe; Balato, Anna; Bardazzi, Federico; Burlando, Martina; Giovanni Carrera, Carlo; Damiani, Giovanni; Dapavo, Paolo; Dini, Valentina; Franchi, Chiara; Maria Gaiani, Francesca; Girolomoni, Giampiero; Guarneri, Claudio; Lasagni, Claudia; Loconsole, Francesco; Valerio Marzano, Angelo; Maurelli, Martina; Megna, Matteo; Orsini, Diego; Sampogna, Francesca; Travaglini, Massimo; Valenti, Mario; Costanzo, Antonio; Narcisi, Alessandra | |
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS) | 1-gen-2024 | Gargiulo, L; Ibba, L; Malagoli, Piergiorgio; Amoruso, F; Argenziano, G; Balato, A; Bardazzi, F; Burlando, M; Carrera, C G; Damiani, G; Dapavo, P; Dini, V; Fabbrocini, G; Franchi, C; Gaiani, F M; Girolomoni, G; Guarneri, C; Lasagni, C; Loconsole, F; Marzano, A V; Maurelli, M; Megna, M; Orsini, D; Sampogna, F; Travaglini, M; Valenti, M; Costanz, o. A.; Narcisi, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile